Reversible Keratopathy Due to Hypertyrosinaemia Following Intermittent Low-Dose Nitisinone in Alkaptonuria: A Case Report

Natural History of Alkaptonuria

Chanika Phornphutkul, Wendy J. Introne, Monique B. Perry et al. · New England Journal of Medicine · 2002 · 655 citations · Full text

Life Sciences, Genetics, Molecular Genetics +4

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase

Sandra Lindstedt · The Lancet · 1992 · 641 citations

Life Sciences, Biochemistry, Pharmacology +10

Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy

William M. O’Brien, Bert N. La Du, Joseph J. Bunim · The American Journal of Medicine · 1963 · 317 citations

Medicine, Pathobiology, Pathology +6

Diurnal variations in plasma concentrations of tryptophan, tyrosine, and other neutral amino acids: effect of dietary protein intake

JD Fernstrom, R. J. Wurtman, B Hammarstrom-Wiklund et al. · American Journal of Clinical Nutrition · 1979 · 254 citations

Life Sciences, Nutritional Sciences, Physiology +12

NTBC treatment in tyrosinaemia type I: Long‐term outcome in French patients

Alice Masurel‐Paulet, Joséphine Poggi-Bach, M. O. Rolland et al. · Journal of Inherited Metabolic Disease · 2008 · 216 citations

Medicine, Hematology, Immunology +2